Immunological consequences of senescence in physiology and pathology.
Understanding how aging cells trigger immune dysfunction opens new targets for combining senescence-targeting drugs with cancer immunotherapy.
This J Translational Medicine review integrates current evidence on how senescence reshapes immune function across both physiological aging and disease pathology, including cancer and metabolic disease. The SASP-immunity axis is increasingly relevant for senolytics and immunotherapy combination approaches.
What the study was
- Study design
- Narrative review
- Population
- General; review of aging and immunity mechanisms
- Category
- Other
- Maturity
- Exploratory
- Journal
- Journal of translational medicine
Why it surfaced
Solid review on immunological consequences of senescence relevant to T8 (aging/longevity). Review-level evidence limits priority but the topic area connection to senolytics and combination immunotherapy makes this pipeline-relevant.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.